YY1 and osteosarcoma: Studies on osteosarcoma have shown that downregulation of YY1 negatively regulates the VEGF/CXCR4 axis pathway, thereby inhibiting angiogenesis and tumor cell migration by reducing the transcription and activity of MMPs [41,42].